MÈRERA THERAPEUTICS

News

Dr Sanja Fitzgerald presenting at W Accelerate 2026 in London, with Merck and W Accelerate branding visible

Company News

MÈRERA Therapeutics Selected for W Accelerate 2026 with Merck KGaA and M Ventures

MÈRERA Therapeutics Selected for W Accelerate 2026 with Merck KGaA and M Ventures

5 October 2026

MÈRERA participated in W Accelerate 2026 in London, presenting its vision for precision protein therapeutics in reproductive medicine.

Read article